Arcutis Biotherapeutics, Inc. (ARQT) Tops Q1 EPS by 1c

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) reported Q1 EPS of ($0.20), $0.01 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $65.8 million versus the consensus estimate of $63.66 million.

For earnings history and earnings-related data on Arcutis Biotherapeutics, Inc. (ARQT) click here.

You May Also Be Interested In

• Jersey Mike's Subs files for IPO on NYSE under ticker JMKE
• Revolution (RVMD) PT Raised to $181 at Wedbush
• Reckitt Unit Cleared By Jury In Premature-infant Formula Case - Bloomberg